Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.35 - $0.74 $65,208 - $137,869
186,310 New
186,310 $70,000
Q4 2022

Feb 14, 2023

BUY
$0.82 - $1.36 $47,341 - $78,516
57,733 New
57,733 $53,000
Q2 2022

Aug 16, 2022

SELL
$1.5 - $2.57 $103,917 - $178,044
-69,278 Reduced 81.55%
15,669 $34,000
Q1 2022

May 17, 2022

SELL
$1.99 - $3.0 $50,508 - $76,143
-25,381 Reduced 23.01%
84,947 $197,000
Q4 2021

Feb 15, 2022

SELL
$2.14 - $3.31 $168,028 - $259,894
-78,518 Reduced 41.58%
110,328 $341,000
Q3 2021

Nov 16, 2021

SELL
$2.86 - $4.21 $262,482 - $386,381
-91,777 Reduced 32.7%
188,846 $559,000
Q2 2021

Aug 16, 2021

BUY
$3.21 - $5.62 $850,788 - $1.49 Million
265,043 Added 1701.17%
280,623 $1.3 Million
Q1 2021

May 18, 2021

SELL
$2.16 - $4.26 $161,688 - $318,886
-74,856 Reduced 82.77%
15,580 $51,000
Q4 2020

Feb 17, 2021

BUY
$0.66 - $2.54 $7,058 - $27,162
10,694 Added 13.41%
90,436 $199,000
Q3 2020

Nov 17, 2020

SELL
$0.56 - $0.82 $623,543 - $913,045
-1,113,470 Reduced 93.32%
79,742 $51,000
Q2 2020

Aug 17, 2020

BUY
$0.67 - $1.03 $799,452 - $1.23 Million
1,193,212 New
1,193,212 $912,000
Q4 2019

Feb 14, 2020

SELL
$0.82 - $2.24 $8,603 - $23,502
-10,492 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.36 - $2.4 $14,269 - $25,180
10,492 New
10,492 $24,000
Q4 2018

Feb 15, 2019

SELL
$2.15 - $3.11 $70,958 - $102,642
-33,004 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$2.28 - $2.93 $75,249 - $96,701
33,004 New
33,004 $93,000
Q2 2018

Aug 15, 2018

SELL
$2.02 - $2.55 $88,880 - $112,199
-44,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.21 - $4.16 $33,068 - $62,246
14,963 Added 51.53%
44,000 $103,000
Q4 2017

Feb 15, 2018

BUY
$1.99 - $3.41 $57,783 - $99,016
29,037
29,037 $81,000

Others Institutions Holding XXII

About 22nd Century Group, Inc.


  • Ticker XXII
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Tobacco
  • Shares Outstandng 214,784,992
  • Market Cap $146M
  • Description
  • 22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King n...
More about XXII
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.